Product Launches Was the Most-widely Adopted Growth Strategy by Key Players in the Top 10 Cellular Analysis Market

The top 10 cellular analysis market is expected to reach USD 41.34 billion by 2021 from USD 28.66 billion in 2016, at a CAGR of 7.6% during the forecast period. Factors such as increasing number of cancer cases, growing number of biotechnology and pharmaceutical industries, increasing investments by various government associations, rising incidence of infectious diseases, and technological advancements in cell biology instruments are driving the growth of the top 10 cellular analysis market.

View more detailed TOC @

https://www.marketsandmarkets.com/Market-Reports/top-10-cellular-analysis-market-247924081.html 

The top 10 cellular analysis market is consolidated in nature due to the presence of a few large players. The prominent players in this market include Bio-Rad Laboratories (U.S.), Thermo Fisher Scientific Inc. (U.S.), Agilent Technologies (U.S.), Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Merck KGaA (Germany), GE Healthcare (U.S.), Olympus Corporation (Japan), Tecan Group (Switzerland), and Nikon Instruments (Japan).

Thermo Fisher Scientific Inc. (U.S.) held the leading position in the top 10 cellular analysis market in 2015. The company focuses on acquisitions, agreements, and expansions to enhance its product portfolio. For instance, in September 2016, the company acquired FEI Company, Inc. (U.S.), a leader in high-performance electron microscopy, for approximately USD 4.2 billion. In November 2015, the company collaborated with the Singapore General Hospital (SGH) to conduct research on the identification of genetic mutations in cancer linked with Asian populations. In September 2015, it acquired Alfa Aesar (U.S.), a manufacturer of research chemicals from Johnson Matthey Plc (U.K.), for USD 400 million (GBP 256 million).

Merck KGaA (Germany) held the second position in the top 10 cellular analysis market in 2015. The company focuses on product launches and acquisitions as its key strategies to in order to increase its share and further strengthen its position in the top 10 cellular analysis market. For instance, in May 2016, Merck Millipore (U.S.), a life sciences subsidiary of Merck KGaA (Germany), expanded its popular line of Guava flow cytometers by including a high-power modulated green laser. In November 2015, Merck KGaA (Germany) acquired Sigma-Aldrich Corporation (U.S.), a leading player in the cell analysis consumables market. 

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=247924081

The key strategies followed by most companies in the top 10 cellular analysis market are product launches, agreements, acquisitions, and expansions. Product launches accounted for the largest share of the total developments in the top 10 cellular analysis market from 2014 to 2016. Some of the leading players that adopted this strategy include Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Agilent Technologies, Inc. (U.S.), Becton, Dickinson and Company (U.S.), and Beckman Coulter, Inc. (U.S.). Agreements accounted for the second-largest share of the total developments in the top 10 cellular analysis market from 2014 to 2016. Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), and Becton, Dickinson and Company (U.S.) are the leading manufacturing companies that adopted this strategy.